As in healthy individuals vaccinated with COVID-19 mRNA vaccines [51], TH1 responses, characterized by the production of IFN-γ, IL-2, and TNF-α, are likewise produced by T cells from IBD patients regardless of treatment following SARS-CoV-2 Spike peptide stimulation. This evidence concerns the gene IFNG and inflammatory bowel disease.